Mayo Clinic questions FDA drug warning

October 1, 2007

A Mayo Clinic study has brought into question a U.S. Food and Drug Administration warning about the use of a medication to control nausea during surgery.

The 2001 FDA warning against using droperidol was based on concerns the drug contributed to potentially fatal heart arrhythmias.

The Mayo Clinic compared 139,932 patients' responses before the warning was issued and found no proven cases of complications directly attributable to droperidol. In comparison, after the FDA warning, two of 151,256 patients suffered poor heart rhythm while receiving alternative medications. The percentage of patients who received droperidol was 12 percent prior to the warning and 0 percent after the FDA warning was issued.

Based on their findings, Mayo Clinic anesthesiologists said they believe the FDA warning was unnecessary.

"In our study, we obtained results that were just the opposite of what the FDA action would predict," said Dr. Gregory Nuttal, the study's lead investigator. "We actually had fewer complications with droperidol."

The study is believed the first large, statistically well-controlled investigation of patient responses to droperidol at a single medical center over a long period of time and which included treatment before and after the FDA warning.

Copyright 2007 by United Press International

Explore further: FDA warns: Swine flu scams lurk on the Internet

Related Stories

FDA warns of fractures with osteoporosis drugs

October 13, 2010

(AP) -- Government health officials warned doctors and patients Wednesday about an increased risk of thigh fractures with a widely used group of bone-strengthening drugs.

Impact of FDA safety warnings examined

January 11, 2010

A study published today in the Archives of Internal Medicine examines the impact of a safety warning issued by the Food and Drug Administration for commonly prescribed antipsychotic medications. The results show the warnings ...

FDA to review first of 3 new weight loss drugs

July 12, 2010

(AP) -- Dieters, doctors and investors get their first extensive look at the first of a trio of new weight loss drugs this week. The hope is that the new drugs can succeed where many others have failed: delivering significant ...

Newer antidepressants led to less, not more, teen suicides

September 7, 2007

A new study by researchers at the University of South Florida and University of Illinois suggests FDA mandated warnings about suicide in teens treated with antidepressants could have the unintended consequence of placing ...

FDA panel: Diabetes drug should stay on market

July 14, 2010

(AP) -- A majority of federal health experts voted Wednesday to keep the controversial diabetes pill Avandia on the market despite evidence that it increases the risk of heart attack.

Recommended for you

How the finch changes its tune

August 3, 2015

Like top musicians, songbirds train from a young age to weed out errors and trim variability from their songs, ultimately becoming consistent and reliable performers. But as with human musicians, even the best are not machines. ...

Machine Translates Thoughts into Speech in Real Time

December 21, 2009

( -- By implanting an electrode into the brain of a person with locked-in syndrome, scientists have demonstrated how to wirelessly transmit neural signals to a speech synthesizer. The "thought-to-speech" process ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.